In the same hot technology area. So could say valuation should be on similar paths (which is why all SHs should be smiling IMO). But different immune check pionts I believe (seems Regen's is more important IHO). Different drugs. And importantly, RGBP has it's own patents. If you want to get fired up: (1) read the patents, (2) look at the comps, (3) read recent press releases about test results, and (4) look at profile of company doing the testing (we are talking about an independant entity big time reputation in BP!). Lots of positive DD out there.
News 
Market Data 
Discover 
